ArriVent BioPharma, Inc. (AVBP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for ArriVent BioPharma, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Valuation | |||||
| P/E Ratio | -4.65x | -10.42x | -9.22x | -18.15x | -0.49x |
| P/B Ratio | 2.52x | 3.25x | 4.22x | 3.84x | 0.62x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | |||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | |||||
| Current Ratio | 12.83x | 13.14x | 13.76x | 21.84x | 23.63x |
| Quick Ratio | 12.83x | 13.14x | 13.76x | 21.84x | 23.63x |
| Leverage | |||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..